Filter
4510
Filtered Results: 4510
Text search:
use
of
medicines
Featured
Recommendations
475
New Publications
1247
Language
Document type
No document type
2356
Studies & Reports
763
Guidelines
637
Manuals
255
Strategic & Response Plan
196
Fact sheets
115
Training Material
78
Situation Updates
47
Brochures
20
Resource Platforms
19
Infographics
12
Online Courses
10
Videos
2
Countries / Regions
India
235
Global
184
Kenya
147
South Africa
112
Ethiopia
103
Uganda
101
Nepal
90
Sierra Leone
89
Africa
87
Western and Central Europe
85
Liberia
83
Nigeria
83
Malawi
73
Myanmar / Burma
71
Ghana
70
Tanzania
69
Bangladesh
68
Zambia
67
Ukraine
61
Latin America and the Carribbean
59
Rwanda
54
Syria
45
Namibia
43
Congo, Democratic Republic of
39
Philippines
39
Eastern Europe
37
South–East Asia Region
34
Zimbabwe
33
Asia
27
Mozambique
25
Haiti
23
East and Southern Africa
23
West and Central Africa
23
Cambodia
22
Lesotho
22
Venezuela
22
Guinea
21
South Sudan
21
Botswana
21
Middle East and North Africa
21
Burkina Faso
20
Senegal
20
Russia
20
Indonesia
19
Eastern Europe and Central Asia
17
Yemen
16
Brazil
15
Pakistan
14
Sudan
13
Eswatini/ Swaziland
13
Cameroon
12
Western Pacific Region
12
Afghanistan
11
Madagascar
11
Somalia
9
Germany
9
Lebanon
9
Moldova
9
Thailand
8
Benin
8
Peru
8
Colombia
8
Georgia
8
Mali
7
Central African Republic
7
Vietnam
7
North America
7
Jordan
6
China
6
North Macedonia
6
Bolivia
6
Paraguay
6
Laos
6
Tajikistan
6
Iraq
5
Ecuador
5
Poland
5
Palestine
5
Albania
5
Southern Africa
5
Côte d’Ivoire / Ivory Coast
4
Argentina
4
Hungary
4
Libya
4
Mexico
4
Sri Lanka
4
Bhutan
4
Kyrgyzstan
4
United Kingdom
4
Morocco
3
USA
3
Saudi Arabia
3
Niger
3
Egypt
3
Papua New Guinea
3
Serbia
3
El Salvador
3
Chile
3
Fiji
3
Armenia
3
Romania
3
Iran
3
Jamaica
3
Mauritius
3
Turkey
2
Chad
2
Gambia
2
Angola
2
Canada
2
Timor Leste/ East Timor
2
Qatar
2
Bulgaria
2
Kazakhstan
2
Gabon
2
Turkmenistan
2
Japan
2
Tunisia
2
Guinea-Bissau
1
Togo
1
Malaysia
1
Switzerland
1
Burundi
1
Honduras
1
Greece
1
Guatemala
1
Nicaragua
1
Other region
1
Solomon Islands
1
Djibouti
1
Mongolia
1
Congo-Brazzaville
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Australia
1
Uruguay
1
Denmark
1
France
1
Maldives
1
Norway
1
Portugal
1
Spain
1
Belarus
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1803
Clinical Guidelines
415
Public Health
278
Women & Child Health
204
Key Resources
114
Capacity Building
88
Pharmacy & Technologies
51
Annual Report MEDBOX
2
Protection & Security
1
Toolboxes
HIV
366
COVID-19
357
TB
280
AMR
278
Mental Health
274
Pharmacy
213
NCDs
139
Caregiver
128
Conflict
108
Disability
103
Ebola
95
Rapid Response
89
NTDs
88
Planetary Health
86
Refugee
75
Global Health Education
70
Natural Hazards
45
Health Financing Toolbox
40
Zika
19
Cholera
12
Polio
12
Specific Hazards
11
Social Ethics
7
Health Financing
2
In recognition of the growing problem of antimicrobial resistance (AMR), its increasing threat to human, animal and plant health, and the need for a One Health approach to address this issue, the 39...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects ... a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial resistance occurs naturally but misuse of antibiotics in human and animals significantly accelerates the process of developing antimicrobial resistance. In fact, antimicrobial resistance refers to the resistance of a microorganism to one or more antimicrobial drugs which had been previously sensitive to these drugs. Antimicrobial resistance can occur in a wide variety of pathogens including bacteria, parasites, viruses, fungi, and cancer cells and may threaten the life of every person, in every age, and in every country
This document provides guidance for African Union Member States on actions to be taken to ensure they continue to meet all the health
needs of their citizens in accordance with achieving the objectives of... the Africa Health Strategy 2016 – 2030.
2020 is a critical year for our Joint Programme as we collectively define the path to getting back on track to ending the AIDS epidemic by 2030. Our revised timelines for adoption of the next strategy are highly ambitious. We need the full support <... all the tremendously dedicated people in UNAIDS-within our staff, our board and all our stakeholders to make this happen.
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was a...
Guidelines on the management of chronic pain in children, developing and implementing national and local policies for pain management and protocols in children, implementing national and local regulations for pain management in children, pain manag...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral ...
The objective of this project was to list the medical devices required to provide the essential reproductive, maternal, newborn and child health interventions defined by existing WHO guidelines and publications, in order to improve access to these d...
This document outlines why and how nurses and midwives are important, not only for individual health optimization but also to achieve the thematic priorities of For the Future. More specifically, it provides case studies to showcase the amazing work...
September – December 2021
The funds will be used by WHO to ensure:
continued coordination with other agencies and health actors in the response to the crisis situation
continuity of health services for the population ... Afghanistan
provision of life-saving medical supplies
continued response to COVID-19
timely response to potential outbreaks
response to urgent trauma needs
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited a...
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicabl...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
A System of Health Accounts 2011: Revised Edition provides an updated and systematic description of the financial flows related to the consumption of...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause ... death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the 3906 notified TB patients were tested for RR-TB and only 12 lab confirmed RR-TB patients were initiated on standard MDR-TB treatment of 20-months duration, (a 3-fold increase in RR-TB detection compared with 2017). This amounts to treatment coverage of only 17% of 72 estimated MDR/RR-TB among notified TB patients (3906) and 5% of 240 estimated incident MDR-TB patients as compared to 62% treatment coverage of 6300 incident drug sensitive TB patients estimated in TLS. The treatment success in the 2016 annual cohort of 6 MDR-TB patients has been reported at 83%. 80% of TB patients know their HIV Status with around 1% TB-HIV co-infection, 37/ 77 (48%) TB-HIV Co-infection Detected. Of the 387 PLHIV currently alive on ART, exact status on TB screening and testing is unknown. % of PLHIV newly enrolled in HIV care who received IPT is not known.
In 2018, the mortality rate for TB was 94 deaths per 100,000 people (1200 per annum) in TL with an increasing mortality trend (Figure 1), despite TB services being available for nearly two decades.
A survey of catastrophic costs due to TB (2016) highlights that 83% of TB patients are reported to be facing catastrophic costs due to the disease. This is the highest rate in the world.
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is athe...
Hypertension is the number one health related risk factor in India, with the largest contribution to burden of disease and mortality. It contributes to an estimated 1.6 million deaths, due to ischemic heart disease and stroke, out ... a total of about 10 million deaths annually in India. Fifty seven percent of deaths related to stroke and 24% of deaths related to coronary heart disease are related to hypertension. Hypertension is one of the commonest non-communicable diseases in India, with an overall prevalence of 29.8% among the adult population, and a higher prevalence in urban areas (33.8% vs. 27.6%)
according to recent estimates.
Awareness of hypertension in India is low while appropriate treatment and control among those with hypertension is even lower: Hypertension is a chronic, persistent, largely asymptomatic disease. A majority of the patients with hypertension in India are unaware of their condition. This is because of low levels of awareness and the lack of screening for hypertension in adults-either as a systematic programme or as an opportunistic exercise during visits to healthcare providers.
